СПОСІБ ЛІКУВАННЯ ЛАТЕНТНОЇ ІШЕМІЧНОЇ ХВОРОБИ СЕРЦЯ У ХВОРИХ НА БРОНХІАЛЬНУ АСТМУ

摘要

The method for treating the bronchial asthma in the patients with the latent course of the ischemic heart disease comprises the use of antihypoxant therapy in the setting of the basic therapy of the bronchial asthma. In the case of low-symptom course of the ischemic heart disease with the impaired repolarization phase, Cratal is prescribed for 4 weeks. In the case of arhythmogenic ischemic heart disease without ST depression with tachycardia syndrome. Coraxan is prescribed for 3 weeks. In bradyarrhythmia with the impaired conductivity and asthma attacks in the night, Nicorandil is prescribed for 14 days.